These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31218401)

  • 21. The role of
    Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-phenotype correlation in Taiwanese children with diazoxide-unresponsive congenital hyperinsulinism.
    Lee CT; Tsai WH; Chang CC; Chen PC; Fann CS; Chang HK; Liu SY; Wu MZ; Chiu PC; Hsu WM; Yang WS; Lai LP; Tsai WY; Yang SB; Chen PL
    Front Endocrinol (Lausanne); 2023; 14():1283907. PubMed ID: 38033998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical features of 123 patients with hyperinsulinemic hypoglycemia auxiliarily diagnosed by
    Zhang MY; Ni JW; Ge JJ; Guan YH; Pei Z; Sun CJ; Wu J; Xu ZR; Yang L; Luo FH; Cheng RQ
    Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):853-858. PubMed ID: 34587682
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
    Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
    Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.
    Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ABCC8, KCNJ11 and GLUD1 gene mutation analysis in congenital hyperinsulinism pedigree].
    Xu ZD; Yu HF; Sang YM; Zhang YN; Yan J; Wu YJ; Zhu C; Ni GC
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1089-92. PubMed ID: 23902843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery in Focal Congenital Hyperinsulinism (CHI) - The "Hyperinsulinism Germany International" Experience in 30 Children.
    Barthlen W; Varol E; Empting S; Wieland I; Zenker M; Mohnike W; Vogelgesang S; Mohnike K
    Pediatr Endocrinol Rev; 2016 Dec; 14(2):129-137. PubMed ID: 28508606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
    Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia.
    Senniappan S; Sadeghizadeh A; Flanagan SE; Ellard S; Hashemipour M; Hosseinzadeh M; Salehi M; Hussain K
    BMC Res Notes; 2015 Aug; 8():350. PubMed ID: 26268944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism.
    Banerjee I; Avatapalle B; Padidela R; Stevens A; Cosgrove KE; Clayton PE; Dunne MJ
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):803-13. PubMed ID: 23347463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
    Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11.
    Hewat TI; Yau D; Jerome JCS; Laver TW; Houghton JAL; Shields BM; Flanagan SE; Patel KA
    Eur J Endocrinol; 2021 Oct; 185(6):813-818. PubMed ID: 34633981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update of variants identified in the pancreatic β-cell K
    De Franco E; Saint-Martin C; Brusgaard K; Knight Johnson AE; Aguilar-Bryan L; Bowman P; Arnoux JB; Larsen AR; Sanyoura M; Greeley SAW; Calzada-León R; Harman B; Houghton JAL; Nishimura-Meguro E; Laver TW; Ellard S; Del Gaudio D; Christesen HT; Bellanné-Chantelot C; Flanagan SE
    Hum Mutat; 2020 May; 41(5):884-905. PubMed ID: 32027066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congenital hyperinsulinism in two siblings with ABCC8 mutation: same genotype, different phenotypes.
    Sousa-Santos F; Simões H; Castro-Feijóo L; Rodríguez PC; Fernández-Marmiesse A; Fiaño RS; Rego T; Carracedo Á; Conde JB
    Arch Endocrinol Metab; 2018 Oct; 62(5):560-565. PubMed ID: 30462810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Genetic Characterization of 153 Patients with Persistent or Transient Congenital Hyperinsulinism.
    Männistö JME; Maria M; Raivo J; Kuulasmaa T; Otonkoski T; Huopio H; Laakso M
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32170320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
    J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. F-18 DOPA PET/CT in pediatric patients with hyperinsulinemic hypoglycemia: A correlation with genetic analysis.
    Sagar S; Arora G; Damle N; Sharma R; Jain V; Jana M; Tripathi M; Bal C; Goel P
    Nucl Med Commun; 2022 Apr; 43(4):451-457. PubMed ID: 35045547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
    Al-Balwi R; Al-Atawi M; Al-Otaibi A; Babiker O; Al-Mutair A
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1013-1017. PubMed ID: 28787272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid genetic analysis in congenital hyperinsulinism.
    Christesen HB; Brusgaard K; Alm J; Sjöblad S; Hussain K; Fenger C; Rasmussen L; Hovendal C; Otonkoski T; Jacobsen BB
    Horm Res; 2007; 67(4):184-8. PubMed ID: 17114887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Congenital hyperinsulinism in newborn and infant].
    Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
    Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.